Lipocine

-$0.01 (-0.75%) Today
+$0.07 (+5.30%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Lipocine and other ETFs, options, and stocks.

About LPCN

Lipocine, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development for the delivery of drugs using proprietary delivery technology. The firm involves in applying oral drug delivery technology for the development of pharmaceutical products focusing on metabolic and endocrine disorders.

CEO
Mahesh V. Patel
Employees
11
Headquarters
Salt Lake City, Utah
Founded
2011

LPCN Key Statistics

Market Cap
116.54M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
380.19K
High Today
$1.35
Low Today
$1.29
Open Price
$1.33
Volume
347.06K
52 Week High
$2.42
52 Week Low
$1.09

LPCN Earnings

-$0.14
-$0.09
-$0.05
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 13, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure